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Case Report {#sec1_1}
===========

A 74-year-old woman with no prior history of cutaneous or internal malignancy presented to our dermatology department for a 2-week history of a growing lesion on her right tragus with associated numbness and tingling. Clinical exam revealed a 7-mm firm, pink to violaceous papule (Fig. [1](#F1){ref-type="fig"}). Shave biopsy showed nests of keratinocytes lacking peripheral palisading, suggestive of the surface of an adnexal neoplasm. The patient was referred for excision to better characterize the lesion. On surgical evaluation, the lesion was tender and felt fixed to the underlying tragus. It measured 2 cm at the greatest palpable dimension without associated lymphadenopathy.

Diagnosis and Clinical Course {#sec1_2}
=============================

Pathology from incisional biopsy was consistent with an endocrine mucin-producing sweat gland carcinoma (EMPSGC), present at the deep margin. Of note, the patient had no history of breast cancer, and a normal mammogram the month before. Computed tomography of the neck did not show involvement of deeper structures or lymphadenopathy. She underwent excision with 1-cm margins as well as resection of the tragal cartilage. Pathology showed an infiltrative carcinoma with extensive vascular invasion, perineural invasion (PNI), and a focal associated mucinous carcinoma, with infiltrating carcinoma present at the deep margin (Fig. [2](#F2){ref-type="fig"},Fig. [3](#F3){ref-type="fig"}). The tumor was immunoreactive for keratin 7, chromogranin, synaptophysin, androgen receptor, and estrogen receptor − an immunoprofile supportive of EMPSGC. She underwent re-excision of the right preauricular skin and additional medial tragal soft tissue and cartilage which showed residual carcinoma present adjacent to cartilage, all margins were negative for malignancy. Based on the indistinct margins of the tumor, deep invasion to cartilage, and perineural spread, a multidisciplinary team recommended adjuvant radiation. The patient received a total of 60 Gy of radiation in 30 fractions to the surgical site, ipsilateral parotid gland and neck (level 2/3 lymph nodes). She is being followed clinically every 3 months, with repeat imaging every 6 months. She has had no evidence of recurrence in an 18-month follow-up period since completing her radiation treatments.

Discussion {#sec1_3}
==========

EMPSGC is a rare, slow-growing tumor that generally presents as a solitary, asymptomatic nodule on the eyelid of elderly individuals \[[@B1], [@B2]\]. Local recurrence may occur following surgical excision \[[@B3]\]; however, there have been no reported cases of lymph node involvement or distant metastases.

EMPSGC is a primary skin tumor characterized by well-defined nodules of uniform polygonal epithelial cells with bland nuclei \[[@B3]\]. Several studies have demonstrated that EMPSGC may be a precursor lesion to invasive mucinous carcinoma in the skin given synchronous presentations \[[@B1]\]. As this tumor is morphologically similar to endocrine ductal carcinoma in situ of the breast, metastatic breast cancer should be considered in the differential diagnosis \[[@B1], [@B3]\].

Prior reports of EMPSGC with or without invasive mucinous carcinoma describe an indolent tumor that lacks vascular invasion or PNI. PNI and lymphovascular invasion have been documented in other sweat gland tumors, which can behave aggressively, and be more likely to recur or metastasize \[[@B4], [@B5]\]. Treatment for EMPSGC typically consists of tumor extirpation via wide local excision or Mohs surgery \[[@B1], [@B2]\]. Due to high-risk histologic features and deep extension of this preauricular tumor, the patient was treated with wide local excision followed by adjuvant radiation to reduce the risk of recurrence and treat the at-risk regional lymph nodes. While this treatment has not been reported in EMPSGC, surgery followed by adjuvant radiation in adnexal tumors of the head and neck with high-risk features has shown promise to improve locoregional control \[[@B5]\].
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![A 7-mm firm, violaceous papule on the right tragus is shown.](dpa-0006-0271-g01){#F1}

![An infiltrative carcinoma with cribriform architecture and associated mucinous component is noted (100×). Vascular invasion is noted in the upper right-hand corner (arrow, 400×) and shown at higher magnification in the **inset**.](dpa-0006-0271-g02){#F2}

![Perineural invasion is seen in the lower right-hand corner (400×).](dpa-0006-0271-g03){#F3}
